LGD 1550

Drug Profile

LGD 1550

Alternative Names: ALRT 1550; ALRT 550; LG 1550

Latest Information Update: 10 Jul 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Allergan; Ligand Pharmaceuticals
  • Class Retinoids; Small molecules
  • Mechanism of Action Retinoic acid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Acne; Cervical cancer; Haematological malignancies; Head and neck cancer; Psoriasis; Solid tumours

Most Recent Events

  • 10 Jul 2007 Discontinued - Phase-II for Cervical cancer in USA (PO)
  • 10 Jul 2007 Discontinued - Phase-II for Haematological malignancies in USA (PO)
  • 10 Jul 2007 Discontinued - Phase-II for Head and neck cancer in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top